| abstract |
Medicines which are characterized by a combination of cytostatic agents or therapeutic hormonal agents and one or more phosphone derivatives, in particular female diphosphonates, phosphonocarboxylic acids or amino acids (methylenephosphonic acids), can be used in the treatment of cancer, including malignomas causing bone metastates. |